Author:
Pallotti Francesco,Buonacquisto Alessandra,Pitton Sara,Abdel Malek Roberto,Ruberto Marta,Faja Fabiana,Gatta Valentina,Paoli Donatella,Lombardo Francesco
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. (2017) Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 102(11):3869–3903
2. Fisher AD, Senofonte G, Cocchetti C, et al. (2022) SIGIS-SIAMS-SIE position statement of gender affirming hormonal treatment in transgender and non-binary people. J Endocrinol Invest 45(3):657–673
3. Pallotti F, Senofonte G, Konstantinidou F, et al. (2022) Epigenetic effects of gender-affirming hormone treatment: a pilot study of the ESR2 promoter’s methylation in AFAB people. Biomedicines 10(2):459
4. Tirabassi G, Cignarelli A, Perrini S, et al. (2015) Influence of CAG repeat polymorphism on the targets of testosterone action. Int J Endocrinol 2015:298107
5. Westberg L, Baghaei F, Rosmond R, et al. (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86(6):2562–2568